Logo
x

Search

Subscribe Now

All Posts by Date

AstraZeneca Collaborates with RenalytixAI to Develop Precision Medicine for Chronic Diseases

AstraZeneca Collaborates with RenalytixAI to Develop Precision Medicine for Chronic Diseases

  • August 24, 2020
Vertex's Kaftrio + Ivacaftor Receive the EC's Approval to Treat Cystic Fibrosis in People Aged 12 Years and Older

Vertex's Kaftrio + Ivacaftor Receive the EC's Approval to Treat Cystic Fibrosis in People Aged 12 Years and Older

  • August 24, 2020
Chugai's Kadcyla (trastuzumab emtansine) Receives MHLW's Approval for Adjuvant Therapy of HER2-Positive Early Breast Cancer

Chugai's Kadcyla (trastuzumab emtansine) Receives MHLW's Approval for Adjuvant Therapy of HER2-Positive Early Breast Cancer

  • August 24, 2020
Takeda to Divest its Consumer Health Unit to Blackstone for $2.3B in Japan

Takeda to Divest its Consumer Health Unit to Blackstone for $2.3B in Japan

  • August 24, 2020
ReiThera Reports First Patient Dosing with its COVID-19 Vaccine Candidate in Italy

ReiThera Reports First Patient Dosing with its COVID-19 Vaccine Candidate in Italy

  • August 24, 2020
BMS to Acquire Forbius for its AVID200 to Expand its Footprints in Oncology and Fibrosis

BMS to Acquire Forbius for its AVID200 to Expand its Footprints in Oncology and Fibrosis

  • August 24, 2020
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.